Tumoral CD8+ T cell populations were greater for animals that received anti-TNFR2 mAbs than for controls (as a proportion of total tumoral CD45+ cells, Figure 5F), resulting in increased CD8+ T cell/Treg ratios (Figure 5G). Here, CD8A is linked to neoplasm.